Company Overview
EdisBiotech, a company leading precision medicine through biomarker-based therapeutic antibody development
EdisBiotech
Global company developing antibody-based pharmaceuticals
OUR STRENTH
- Clinically applicable drug development
- Distinctive R&D capabilities
- Highly experienced key members
- Strong collaboration with industry-academia-hospitals
- Solid partnership
OUR CAPABILITY
- Efficient drug development through CTA platform
- Securing key biomarkers and novel drug target candidates for gastrointestinal cancers
- Excellence rating in the NICE Technical Appraisal
- Therapeutic antibody development for GI cancers
- Selected as a ‘Baby Unicorn Company’
Breakthrough Solutions for Cancer Diseases
-
Tech
Technology to acquire patient-derived biomarkers
-
R&D
Biomarker-based drug development
-
Pipeline
Innovative drugs overcome the limitations of on-market treatments
-
Capability
Strategic Development Capabilities with Solid Infrastructure
-
Global
Global network